Inhibition of human cytomegalovirus DNA replication with a phosphorothioate cholesteryl-modified oligonucleotide is mediated by rapid cellular association and virus-facilitated nuclear localization

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 3, 1997, Pages 255-264

  Zhang, Z ^a   Smith, J A ^a   Smyth, A P ^a   Tang, J Y ^a   Eisenberg, W ^a   Pari, G S ^a  

^a HYBRIDON INC   (United States)

Author keywords

antisense; cholesteryl; Human cytomegalovirus

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTIVIRUS AGENT; CHOLESTEROL DERIVATIVE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; UL 36 ANTI; UL 36 ANTI M; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DNA REPLICATION; DRUG STRUCTURE; DRUG SYNTHESIS; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0030907603     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800309     Document Type: Article

References (21)

1. Bennett CF, Chiang M-Y, Chan H, Shoemaker JEE & Mirabelli CK (1992) Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Molecular Pharmacology 41: 1023-1033.
2. Boutorin AS, Gus'kova LV, Ivanova EM, Kobertz ND, Zarytova VF, Ryte AS, Yurchenko LV & Vlassov W (1989) Synthesis of alkylating oligonucleotide derivatives containing cholesterol of phenazinium residues at their 3′-terminus and their interaction with DNA within mammalian cells. FEBS Letters 254: 129-132.
3. Buckheit RW, Robertson JL, Lackman-Smith C, Wyatt JR, Vickers TA & Ecker DJ (1994) Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320). AIDS Research and Human Retroviruses 10: 1497-1506.
4. Colberg-Poley AM, Santomenna LD, Harlow PP, Benfield PA & Tenney DJ (1992) Human cytomegalovirus UL3 and UL36-38 immediate-early proteins regulate gene expression. Journal of Virology 66: 95-105.
5. Crooke RM (1993) Cellular uptake, distribution and metabolism of phosphorothioate, phosphodiester, and methylphosphonate oligonucleotides. In Antisense Research and Applications. Edited by ST Crooke and B Lebleu. Boca Raton: CRC Press, pp. 427-449.
6. Gao WTW, Jaroszewski JS, Cohen JS & Chen Y-C (1990) Mechanisms of inhibition of herpes simplex virus type 2 growth by 28-mer phosphorothioate oligodeoxycytidine. Journal of Biological Chemistry 265: 20172-20178.
7. Ho M (1991) Cytomegalovirus Biology and Infection. New York: Plenum Press.
8. Iskenderian AC, Huang LL, Reilly A, Stenberg RM & Anders DG (1996) Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes. Journal of Virology 70: 383-392.
9. Jaroszewski JW & Cohen JS (1990) Cellular uptake of antisense oligodeoxynucleotides. Advanced Drug Delivery Reviews 6: 235-250.
10. Kreig AM, Tonkinson J, Matson S, Zhao Q, Saxon M, Zhang L-M, Bhanja U, Yakubov L & Stein SA (1993) Modification of antisense phosphodiester oligodeoxynucleotides by a 5′-cholesterol moiety increases cellular association and improves efficacy. Proceedings of the National Academy of Sciences, USA 90: 1048-1052.
11. Letsinger RL, Zhang G, Sun DK, Ikeuchi T & Sarin PS (1989) Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture. Proceedings of the National Academy of Sciences, USA 86: 6553-6556.
12. Mocarski ES (1993) Cytomegalovirus biology and replication. In The Human Herpesviruses. Edited by B Roizman, RJ Whitley and C Lopez. New York: Raven Press, pp. 173-226.
13. Pari GS & Anders DG (1993) Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. Journal of Virology 67: 6979-6988.
14. Pari GS, Kacica MA & Anders DA (1993) Open reading frames UL44, IRS1/TRS1, and UL36-38 are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA synthesis. Journal of Virology 67: 2575-2582.
15. Pari GS, Field AK & Smith JA (1995) Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37. Antimicrobial Agents and Chemotherapy 39: 1157-1161.
16. Reed MW, Lukhtanov EA, Gorn VV, Lucas DD, Zhou JH, Pai SB, Cheng Y-C & Meyer RB (1995) Structure - activity relationships of cytotoxic cholesterol-modified DNA duplexes. Journal of Medicinal Chemistry 38: 4587-4596.
17. Smith JA & Pari GS (1995) Expression of human cytomegalovirus UL36 and UL37 genes is required for viral DNA replication. Journal of Virology 69: 1925-1931.
18. Stein CA, Pal R, DeVico AL, Hoke G, Mumbauer S, Kinstler O, Sarngadharan MG & Letsinger RL (1991) Mode of action of 5′-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro. Biochemistry 30: 2439-2444.
19. Tenney DJ & Colberg-Poley AM (1991a) Expression of the human cytomegalovirus UL36-38 immediate early region during permissive infection. Virology 182: 199-210.
20. Tenney DJ & Colberg-Poley AM (1991b) Human cytomegalovirus UL36-38 and UL3 immediate-early genes: temporally regulated expression of nuclear, cytoplasmic, and polysome-associated transcripts during infection. Journal of Virology 65: 6724-6734.
21. Zhang Z, Tang JX & Tang JY (1995) Synthesis and properties of novel thiono-triester modified antisense oligodeoxynucleotide phosphorothioates. Bioorganic and Medicinal Chemistry Letters 5: 1735-1740.